Primary immunodeficiencies: increasing market share

Current Opinion in Immunology

Volumn 21, Issue 5, 2009, Pages 461-465

  Notarangelo, Luigi D ^a   Casanova, Jean Laurent ^b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c IMAGINE INSTITUTE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; INTERLEUKIN 17; STAT3 PROTEIN; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR;

AGAMMAGLOBULINEMIA; AGRANULOCYTOSIS; COMMON VARIABLE IMMUNODEFICIENCY; CROHN DISEASE; CYTOKINE RELEASE; EDITORIAL; GENE MUTATION; GENETIC COUNSELING; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HYPER IGE SYNDROME; IMMUNE DEFICIENCY; LEUKOCYTE ADHESION DEFICIENCY; MALARIA; OPPORTUNISTIC INFECTION; PHENOTYPIC VARIATION; PRIMARY IMMUNODEFICIENCY; SEVERE CONGENITAL NEUTROPENIA; TRYPANOSOMIASIS;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC DEFICIENCY SYNDROMES; OPPORTUNISTIC INFECTIONS;

EID: 70349790195     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2009.09.002     Document Type: Editorial

References (55)

1. Casanova J.L., and Abel L. Primary immunodeficiencies: a field in its infancy. Science 317 (2007) 617-619
2. Pessach I., Walter J., and Notarangelo L.D. Recent advances in primary immunodeficiencies: identification of novel genetic defects and unanticipated phenotypes. Pediatr Res (2009) Jan 28 [Epub ahead of print]
3. Geha R.S., Notarangelo L.D., Casanova J.L., Chapel H., Conley M.E., Fischer A., Hammarstrom L., Nonoyama S., Ochs H.D., Puck J.M., et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 120 (2007) 776-794
4. Bruton O.C. Agammaglobulinemia. Pediatrics 9 (1952) 722-728
5. Conley M.E., Dobbs A.K., Farmer D.M., Kilic S., Paris K., Grigoriadou S., Coustan-Smith E., Howard V., and Campana D. Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol 27 (2009) 199-227
6. Conley M.E. Genetics of hypogammaglobulinemia: what do we really know?. Curr Opin Immunol 21 (2009) 466-471
7. Kostmann R. Infantile genetic agranulocytosis. Acta Pediatr Scand 45 (1956) 1-78
8. Klein C. Novel genetic etiologies of severe congenital neutropenia. Curr Opin Immunol 21 (2009) 472-480
9. Beaudet A.L., Anderson D.C., Michels V.V., Arion W.J., and Lange A.J. Neutropenia and impaired neutrophil migration in type IB glycogen storage disease. J Pediatr 97 (1980) 906-910
10. Boztug K., Appaswamy G., Ashikov A., Schaffer A.A., Salzer U., Diestelhorst J., Germeshausen M., Brandes G., Lee-Gossler J., Noyan F., et al. A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med 360 (2009) 32-43
11. Klein C., Grudzien M., Appaswamy G., Germeshausen M., Sandrock I., Schaffer A.A., Rathinam C., Boztug K., Schwinzer B., Rezaei N., et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 39 (2007) 86-92
12. Germeshausen M., Grudzien M., Zeidler C., Abdollahpour H., Yetgin S., Rezaei N., Ballmaier M., Grimbacher B., Welte K., and Klein C. Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations. Blood 111 (2008) 4954-4957
13. Carlsson G., van't Hooft I., Melin M., Entesarian M., Laurencikas E., Nennesmo I., Trebinska A., Grzybowska E., Palmblad J., Dahl N., et al. Central nervous system involvement in severe congenital neutropenia: neurological and neuropsychological abnormalities associated with specific HAX1 mutations. J Intern Med 264 (2008) 388-400
14. Etzioni A. Genetic etiologies of leucocyte adhesion defects. Curr Opin Immunol 21 (2009) 481-486
15. Alon R., and Etzioni A. LAD-III, a novel group of leukocyte integrin activation deficiencies. Trends Immunol 24 (2003) 561-566
16. Kuijpers T.W., van Bruggen R., Kamerbeek N., Tool A.T., Hicsonmez G., Gurgey A., Karow A., Verhoeven A.J., Seeger K., Sanal O., et al. Natural history and early diagnosis of LAD-1/variant syndrome. Blood 109 (2007) 3529-3537
17. Pasvolsky R., Feigelson S.W., Kilic S.S., Simon A.J., Tal-Lapidot G., Grabovsky V., Crittenden J.R., Amariglio N., Safran M., Graybiel A.M., et al. A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets. J Exp Med 204 (2007) 1571-1582
18. Mory A., Feigelson S.W., Yarali N., Kilic S.S., Bayhan G.I., Gershoni-Baruch R., Etzioni A., and Alon R. Kindlin-3: a new gene involved in the pathogenesis of LAD-III. Blood 112 (2008) 2591
19. Kuijpers T.W., van de Vijver E., Weterman M.A., de Boer M., Tool A.T., van den Berg T.K., Moser M., Jakobs M.E., Seeger K., Sanal O., et al. LAD-1/variant syndrome is caused by mutations in FERMT3. Blood 113 (2009) 4740-4746
20. Malinin N.L., Zhang L., Choi J., Ciocea A., Razorenova O., Ma Y.Q., Podrez E.A., Tosi M., Lennon D.P., Caplan A.I., et al. A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat Med 15 (2009) 313-318
21. Svensson L., Howarth K., McDowall A., Patzak I., Evans R., Ussar S., Moser M., Metin A., Fried M., Tomlinson I., et al. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat Med 15 (2009) 306-312
22. Davis S.D., Schaller J., and Wedgwood R.J. Job's syndrome. Recurrent, "cold", staphylococcal abscesses. Lancet 1 (1966) 1013-1015
23. Buckley R.H., Wray B.B., and Belmaker E.Z. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics 49 (1972) 59-70
24. Minegishi Y., Saito M., Tsuchiya S., Tsuge I., Takada H., Hara T., Kawamura N., Ariga T., Pasic S., Stojkovic O., et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448 (2007) 1058-1062
25. Minegishi Y., Saito M., Morio T., Watanabe K., Agematsu K., Tsuchiya S., Takada H., Hara T., Kawamura N., Ariga T., et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 25 (2006) 745-755
26. Holland S.M., Deleo F.R., Elloumi H.Z., Hsu A.P., Uzel G., Brodsky N., Freeman A.F., Demidowich A., Davis J., Turner M.L., et al. STAT3 mutations in the Hyper-IgE syndrome. N Engl J Med 357 (2007) 1608-1619
27. de Beaucoudrey L., Puel A., Filipe-Santos O., Cobat A., Ghandil P., Chrabieh M., Feinberg J., von Bernuth H., Samarina A., Janniere L., et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med 205 (2008) 1543-1550
28. Ma C.S., Chew G.Y., Simpson N., Priyadarshi A., Wong M., Grimbacher B., Fulcher D.A., Tangye S.G., and Cook M.C. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 205 (2008) 1551-1557
29. Milner J.D., Brenchley J.M., Laurence A., Freeman A.F., Hill B.J., Elias K.M., Kanno Y., Spalding C., Elloumi H.Z., Paulson M.L., et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452 (2008) 773-776
30. Minegishi Y., Saito M., Nagasawa M., Takada H., Hara T., Tsuchiya S., Agematsu K., Yamada M., Kawamura N., Ariga T., et al. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J Exp Med 206 (2009) 1291-1301
31. Pays E. Vanhollebeke B: Human innate immunity against African trypanosomes. Curr Opin Immunol 21 (2009) 493-498
32. Vanhollebeke B., Truc P., Poelvoorde P., Pays A., Joshi P.P., Katti R., Jannin J.G., and Pays E. Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-I. N Engl J Med 355 (2006) 2752-2756
33. Allison A.C. Protection afforded by sickle cell trait against subtertian malarian infection. Br Med J 1 (1954) 290-294
34. Kwiatkowski D.P. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 77 (2005) 171-192
35. Jallow M., Teo Y.Y., Small K.S., Rockett K.A., Deloukas P., Clark T.G., Kivinen K., Bojang K.A., Conway D.J., Pinder M., et al. Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet (2009) May 24 [Epub ahead of print]
36. Allison A.C. Genetic control of innate immunity to malaria. Curr Opin Immunol 21 (2009) 499-505
37. Filipovich A.H. Hemophagocytic lymphohistiocytosis and other hemophagocytic disorders. Immunol Allergy Clin North Am 28 (2008) 293-313 viii
38. Kavanagh D., Richards A., and Atkinson J. Complement regulatory genes and hemolytic uremic syndromes. Annu Rev Med 59 (2008) 293-309
39. Sewell G.W., Marks D.J., and Segal A.W. The immunopathogenesis of Crohn's disease: a three stage model. Curr Opin Immunol 21 (2009) 506-513
40. Smith A.M., Rahman F.Z., Hayee B.H., Graham S.J., Marks D.J.B., Sewell G.W., Palmer C.D., Wilde J., Foxwell B.M.J., Gloger I.S., et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med 206 (2009) 1883-1897
41. Casanova J.L., and Abel L. Revisiting Crohn's disease as a primary immunodeficiency of macrophages. J Exp Med 206 (2009) 1839-1843
42. Noguchi E., Homma Y., Kang X., Netea M.G., and Ma X. A Crohn's disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1. Nat Immunol 10 (2009) 471-479
43. Quintana-Murci L., Alcais A., Abel L., and Casanova J.L. Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases. Nat Immunol 8 (2007) 1165-1171
44. Davis M.M. A prescription for human immunology. Immunity 29 (2008) 835-838
45. Hayday A.C., and Peakman M. The habitual, diverse and surmountable obstacles to human immunology research. Nat Immunol 9 (2008) 575-580
46. Trapnell B.C., Carey B.C., Uchida K., and Suzuki T. Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages. Curr Opin Immunol 21 (2009) 514-521
47. Martinez-Moczygemba M., Doan M.L., Elidemir O., Fan L.L., Cheung S.W., Lei J.T., Moore J.P., Tavana G., Lewis L.R., Zhu Y., et al. Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene in the X chromosome pseudoautosomal region 1. J Exp Med 205 (2008) 2711-2716
48. Suzuki T., Sakagami T., Rubin B.K., Nogee L.M., Wood R.E., Zimmerman S.L., Smolarek T., Dishop M.K., Wert S.E., Whitsett J.A., et al. Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. J Exp Med 205 (2008) 2703-2710
49. Kitamura T., Tanaka N., Watanabe J., Uchida, Kanegasaki S., Yamada Y., and Nakata K. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 190 (1999) 875-880
50. Notarangelo L.D., and Pessach I. Out of breath: GM-CSFRalpha mutations disrupt surfactant homeostasis. J Exp Med 205 (2008) 2693-2697
51. Puel A., Picard C., Lorrot M., Pons C., Chrabieh M., Lorenzo L., Mamani-Matsuda M., Jouanguy E., Gendrel D., and Casanova J.L. Recurrent staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6. J Immunol 180 (2008) 647-654
52. Kampmann B., Hemingway C., Stephens A., Davidson R., Goodsall A., Anderson S., Nicol M., Scholvinck E., Relman D., Waddell S., et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest 115 (2005) 2480-2488
53. Filipe-Santos O., Bustamante J., Chapgier A., Vogt G., de Beaucoudrey L., Feinberg J., Jouanguy E., Boisson-Dupuis S., Fieschi C., Picard C., et al. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 18 (2006) 347-361
54. Vidal S.M., Malo D., Marquis J.F., and Gros P. Forward genetic dissection of immunity to infection in the mouse. Annu Rev Immunol 26 (2008) 81-132
55. Casanova J.L., and Abel L. Inborn errors of immunity to infection: the rule rather than the exception. J Exp Med 202 (2005) 197-201